Showing results (11-20 of 940) with videos related to

Sort By:
Pageof 94
Neurology and Therapy|February 22, 2022
The Humanistic and Economic Burden of Alzheimer's DiseaseAmir Abbas Tahami Monfared, Michael J Byrnes, Leigh Ann White, et al.
Neurology and Therapy|October 20, 2021
Sleep Apnea and Serum Serotonin Level Pre- and Post-PAP Therapy: A Preliminary StudyIrina M Madaeva, Olga N Berdina, Nadezhda A Kurashova, et al.
Neurology and Therapy|February 17, 2022
Effects of Training with a Brain-Computer Interface-Controlled Robot on Rehabilitation Outcome in Patients with Subacute Stroke: A Randomized Controlled TrialChen-Guang Zhao, Fen Ju, Wei Sun, et al.
Neurology and Therapy|April 5, 2022
Pharmacokinetics of XEN496, a Novel Pediatric Formulation of Ezogabine, Under Fed and Fasted Conditions: A Phase 1 TrialRostam Namdari, Constanza Luzon, Jay A Cadieux, et al.
Neurology and Therapy|March 10, 2022
Results from Patient Interviews on Fatigue in Progressive Multiple Sclerosis and Evaluation of Fatigue Patient-Reported Outcome (PRO) InstrumentsCrystal Watson, Kayla Scippa, Arie Barlev, et al.
Neurology and Therapy|November 3, 2021
Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort StudyRong-Jing Guo, Ting Gao, Zhe Ruan, et al.
Neurology and Therapy|January 22, 2022
A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-InjectorRyan Farej, Mark Rametta, Anneliese La Rose, et al.
Neurology and Therapy|January 31, 2022
Staging Disease Severity Using the Alzheimer's Disease Composite Score (ADCOMS): A Retrospective Data AnalysisAmir Abbas Tahami Monfared, Katherine Houghton, Quanwu Zhang, et al.
Neurology and Therapy|February 11, 2022
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE StudyCaroline Papeix, Giovanni Castelnovo, Emmanuelle Leray, et al.
Neurology and Therapy|December 16, 2022
Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of EplontersenTeresa Coelho, Márcia Waddington Cruz, Chi-Chao Chao, et al.
Pageof 94